Searched for
ANTI RETROVIRAL TREATMENT
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...31 May, 2026, 01.34 PM IST- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- Rhizen Pharmaceuticals gets USFDA approval for phase one clinical trials for Covid-19 drugThe Switzerland-based firm, which is a clinical-stage oncology-focussed biopharmaceutical company, has received approval for its investigat...02 Dec, 2020, 01.48 PM IST
- Parliamentary panel asks health ministry to expedite setting up of anti-retroviral treatment centresThe panel has also asked the ministry to devise a mechanism for providing an expanded access to subsidised anti-retroviral therapy for poor...05 Aug, 2018, 11.50 AM IST
- Hetero launches FDC combination of key HIV drugsThe FDC drug ‘Darunavir+Ritonavir’ is an anti-retroviral medication indicated for the treatment of human immunodeficiency virus (HIV-1) in ...14 Nov, 2017, 05.34 PM IST
- AIDS epidemic can end by 2030: UNAIDSAIDS-related deaths have fallen by 42 per cent since 2004 -- the year that saw the largest number of deaths in the history of the epidemic.14 Jul, 2015, 10.09 PM IST
- Cipla awarded $188.95 million tender by Global Fund for ARV drugs to treat HIV/AIDSCipla has been awarded $188.95 million tender for anti-retrovirals drugs by Global Fund which would enable it to supply the medicines to ov...13 Feb, 2015, 01.33 PM IST
- On World AIDS Day, Larsen & Toubro opens new anti-retroviral therapy centreThe centre, owned by the Municipal Corporation of Greater Mumbai (MCGM), has been built by L&T, which will also operate it.01 Dec, 2014, 10.24 PM IST
- Cipla to develop formulation for HIV +ve children with DNDiCipla will work to produce an appropriate 4-in-1 combination sachet product for easy mixing into food or liquids such as water, juice, or b...21 Jul, 2012, 07.34 PM IST
- Ranbaxy inks pact with Gilead for three generic HIV/AIDS drugsRanbaxy has entered into an agreement with US-headquartered Gilead Sciences to manufacture and market three new generic HIV/AIDS drugs.12 Jul, 2011, 02.47 PM IST
- Drugs by Indian cos reduces cost of HIV first line treatmentGeneric anti-retroviral drugs manufactured by Indian cos have brought down the cost of first line treatment for HIV patients from $800 to $...25 Aug, 2010, 09.24 PM IST
- New, more efficient anti-AIDS drug for untreated patientsMedical researchers on Sunday unveiled clinical trials of new anti-AIDS drug that better controls the spread of the deadly virus among prev...27 Oct, 2008, 08.58 AM IST
- 'Indian generic retrovirals for HIV patients more effective'India has commended the much cheaper generic versions being produced by its companies to help meet the shortfall.13 Jun, 2008, 09.03 PM IST
- The economics of AIDS numbersIn September, the number of people with HIV/AIDS in India was officially revised downwards by half.01 Dec, 2007, 04.30 AM IST
- Strides Arcolab gets US nod for anti-HIV drugPharmaceutical company, Strides Arcolab has received tentative approval from the United States Food and Drug Administration (USFDA) for Efa...28 Mar, 2007, 12.30 PM IST
- JB Chem ties up with US co for anti-HIV drugJB Chemicals & Pharmaceuticals Ltd on Friday said it has signed a non-exclusive license agreement with US-based Gilead Sciences Inc to manu...22 Sep, 2006, 04.00 PM IST
- Matrix signs licensing deal with US coPharmacuetical company, Matrix Laboratories Ltd on Friday said it signed a licensing agreement with Gilead for manufacture and sale of a ge...22 Sep, 2006, 02.20 PM IST
Load More
